BR0111816A - Derivados heterocìclicos de aminoalquilpiridina como psicofarmacêuticos - Google Patents

Derivados heterocìclicos de aminoalquilpiridina como psicofarmacêuticos

Info

Publication number
BR0111816A
BR0111816A BR0111816-1A BR0111816A BR0111816A BR 0111816 A BR0111816 A BR 0111816A BR 0111816 A BR0111816 A BR 0111816A BR 0111816 A BR0111816 A BR 0111816A
Authority
BR
Brazil
Prior art keywords
hal
ring structures
disubstituted
groups
optionally
Prior art date
Application number
BR0111816-1A
Other languages
English (en)
Inventor
Dieter Dorsch
Henning Boettcher
Michael Arlt
Rudolf Gottschlich
Christoph Seyfried
Gerd Bartoszyk
Juergen Harting
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR0111816A publication Critical patent/BR0111816A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"DERIVADOS HETEROCìCLICOS DE AMINOALQUILPIRIDINA COMO PSICOFARMACêUTICOS". A invenção refere-se a derivados heterocíclicos de aminoalquilpiridina de fórmula I onde R^1^ é o radical de um heterociclo que apresenta de 1 a 3 estruturas de anéis, onde cada estrutura de anel é saturada, insaturada ou aromática e opcionalmente fundida com outras estruturas de anéis para fornecer um o sistema de anéis fundidos, e o heterociclo possui um total de 1 a 4 átomos de N, O e/ou S nas estruturas de anéis e é opcionalmente monossubstituído, dissubstituído ou trissubstituído por um ou mais dos grupos -A, -OR^ 4^ -N(R^ 4^)~ 2~, -NO~ 2~, -CN, Hal, -COOR^ 4^, -CON(R^ 4^)~ 2~, -COR^ 4^, =O; R^ 2^ é um grupo fenila que é opcionalmente monossubstituído, dissubstituído, trissubstituído, tetrassubstituído ou pentassubstituído por um ou mais dos grupos Hal, -A, -O-A, -NO~ 2~ ou -CN, ou é um grupo tienila que é opcionalmente monossubstituído ou dissubstituído por um ou mais dos grupos Hal, -A, -O-A, -NO~ 2~, -CN ou tienila; R^ 3^ é H, -A, -CO-A, -C(R^ 4^)~ 2~R^ 2^, -C(R^ 4^)~ 2~-piridinodiil-R^ 2^; R^ 4^ é H ou -A; A é C~ 1~-C~ 6~-alquila, onde de 1 a 7 átomos de hidrogênio são opcionalmente substituídos por flúor; -X- é -O-, -S-, sulfinila, sulfonila, -C(R^ 4^)~ 2~-; -Y- é -[C(R^ 4^)~ 2~]~ n~-; -Z- é -C(R^ 4^)~ 2~-; Hal é F, CI, Br ou I; n é 1, 2, 3 ou 4; e seus sais e solvatos toleráveis e seu uso como medicamentos. Nova página 1 do quadro reivindicatório, incorporando as emendas às reivindicações conforme relatório de Exame Preliminar.
BR0111816-1A 2000-06-20 2001-06-19 Derivados heterocìclicos de aminoalquilpiridina como psicofarmacêuticos BR0111816A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10029371A DE10029371A1 (de) 2000-06-20 2000-06-20 Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka
PCT/EP2001/006915 WO2001098293A1 (de) 2000-06-20 2001-06-19 Heterocyclische aminoalkylpyridinderivate als psychopharmaka

Publications (1)

Publication Number Publication Date
BR0111816A true BR0111816A (pt) 2003-06-24

Family

ID=7645750

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111816-1A BR0111816A (pt) 2000-06-20 2001-06-19 Derivados heterocìclicos de aminoalquilpiridina como psicofarmacêuticos

Country Status (21)

Country Link
US (1) US6960599B2 (pt)
EP (1) EP1292592B1 (pt)
JP (1) JP5160715B2 (pt)
KR (1) KR20030011092A (pt)
CN (1) CN1437595A (pt)
AR (1) AR028968A1 (pt)
AT (1) ATE506357T1 (pt)
AU (2) AU7845701A (pt)
BR (1) BR0111816A (pt)
CA (1) CA2410594C (pt)
CZ (1) CZ20023955A3 (pt)
DE (2) DE10029371A1 (pt)
ES (1) ES2363668T3 (pt)
HU (1) HUP0301316A2 (pt)
MX (1) MXPA02012262A (pt)
NO (1) NO20026104L (pt)
PL (1) PL358672A1 (pt)
RU (1) RU2003100514A (pt)
SK (1) SK17122002A3 (pt)
WO (1) WO2001098293A1 (pt)
ZA (1) ZA200209727B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800652B2 (en) 2002-08-16 2004-10-05 Pfizer Inc. Diaryl compounds
GB0219154D0 (en) * 2002-08-16 2002-09-25 Pfizer Ltd Diaryl compounds
DE10254596A1 (de) * 2002-11-22 2004-06-03 Merck Patent Gmbh Indolderivate
SI1569907T1 (sl) * 2002-12-13 2016-06-30 Ym Biosciences Australia Pty Ltd Na nikotinamidu osnovani kinazni inhibitorji
KR100679480B1 (ko) * 2004-05-18 2007-02-07 엄기형 지하층 바닥에 시공되는 배수판
US8152380B2 (en) * 2006-07-07 2012-04-10 Federal-Mogul World Wide, Inc. Sleeve bearing assembly and method of construction
KR101043454B1 (ko) * 2009-07-10 2011-06-23 현대산업개발 주식회사 건축 지하구조물의 마감 조립체
US9012651B2 (en) * 2011-03-24 2015-04-21 Abbvie Inc. TRPV3 modulators
TW202246215A (zh) 2015-12-18 2022-12-01 美商亞德利克斯公司 作為非全身ｔｇｒ５促效劑之經取代之４－苯基吡啶化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5177088A (en) 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
TW203047B (pt) * 1991-06-21 1993-04-01 American Home Prod
JPH05125024A (ja) * 1991-11-05 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアリールオキシアルキルアミン誘導体又はその塩
JPH05255302A (ja) * 1992-03-09 1993-10-05 Yamanouchi Pharmaceut Co Ltd 新規なクロマニルオキシアルキルアミン誘導体
DE4226527A1 (de) * 1992-08-11 1994-02-17 Merck Patent Gmbh 1,4-Benzodioxanderivate
JPH07309867A (ja) * 1994-05-19 1995-11-28 Asahi Chem Ind Co Ltd トリプタミン誘導体およびその用途
PT707007E (pt) 1994-10-14 2002-06-28 Merck Patent Gmbh Derivados amino(tio)eter como agentes activos no snc
JPH0940648A (ja) * 1995-08-02 1997-02-10 Yamanouchi Pharmaceut Co Ltd 新規な８−（２−アミノアルコキシ）キノリン誘導体
PT923548E (pt) * 1996-08-27 2003-06-30 Wyeth Corp 4-aminoetoxi-indolos como agonistas d2 da dopaminae como ligandos da 5ht1a

Also Published As

Publication number Publication date
DE10029371A1 (de) 2002-01-03
EP1292592B1 (de) 2011-04-20
PL358672A1 (en) 2004-08-09
CA2410594A1 (en) 2001-12-27
ZA200209727B (en) 2004-03-30
SK17122002A3 (sk) 2003-04-01
HUP0301316A2 (hu) 2003-08-28
US6960599B2 (en) 2005-11-01
NO20026104D0 (no) 2002-12-19
AR028968A1 (es) 2003-05-28
KR20030011092A (ko) 2003-02-06
NO20026104L (no) 2002-12-19
CN1437595A (zh) 2003-08-20
ES2363668T3 (es) 2011-08-11
ATE506357T1 (de) 2011-05-15
AU2001278457B2 (en) 2006-10-19
AU2001278457C1 (en) 2002-01-02
AU7845701A (en) 2002-01-02
CA2410594C (en) 2010-10-26
RU2003100514A (ru) 2004-07-20
EP1292592A1 (de) 2003-03-19
CZ20023955A3 (cs) 2003-05-14
US20040019044A1 (en) 2004-01-29
JP5160715B2 (ja) 2013-03-13
WO2001098293A1 (de) 2001-12-27
DE50115858D1 (de) 2011-06-01
JP2004501148A (ja) 2004-01-15
MXPA02012262A (es) 2003-04-25

Similar Documents

Publication Publication Date Title
BRPI0508263A (pt) derivados de 1, 2, 3, 4-tetra-hidro-isoquinolina, composição farmacêutica, e, uso de derivado de 1, 2, 3, 4-tetra-hidro-isoquinolina
BR0111816A (pt) Derivados heterocìclicos de aminoalquilpiridina como psicofarmacêuticos
BR0208192A (pt) Derivados espirotricìclicos e seu uso como inibidores da fosfodiesterase-7.
BR9911182A (pt) Composto, uso do mesmo, processo para o tratamento de um mamìfero, incluindo homem, de condições suscetìveis de melhora por um agonista de beta-adrenorreceptor atìpico, composição farmacêutica, e, processo para a preparação de um composto.
NO20075623L (no) Benzodioksan- og benzodioksolanderivater og deres anvendelse
BR0113120A (pt) Composto ou sal, composição farmacêutica, método para alterar a atividade transdutora de sinal de receptores gabaa, método para o tratamento de ansiedade, depressão, um distúrbio do sono, ou demência de alzheimer, método para demonstrar a presença de receptores de gabaa em amostras de célula ou tecido, embalagem, e, uso de um composto ou sal
BR0111196A (pt) Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus
BR9908757A (pt) Derivados de 3-hidróxi-4-aril-5-oxopirazolina herbicidamente ativos
BR0207715A (pt) Compostos, composições farmacêuticas, e uso de um ou mais compostos
BRPI0108395B8 (pt) derivados de pirrolopirimidinona, processos de preparação e uso
BRPI0709803B8 (pt) compostos moduladores de benzimidazol de vr1, sais, processo de preparação do mesmo, seu uso e composição farmacêutica que os compreende
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
DK0933993T3 (da) Substituerede cyclopentanforbindelser, der er egnede som neuraminidaseinhibitorer
BR0113755A (pt) Composto multimérico, processo para a preparação de composto, composição farmacêutica que compreende o composto, processo para o tratamento e/ou profilaxia e detecção de uma infecção por virus, utilização do composto, e inalador que contém a composição
BR0314353A (pt) Compostos, composições farmacêuticas, uso de um ou mais compostos em combinação com outros compostos farmacologicamente ativos, e, método para tratar um paciente que sofre de um distúrbio
BR0316776A (pt) Formula para anti-infeccioso tópico
BR9810021A (pt) Derivados 9-oxima-eritromicina
BR0012951A (pt) Agonistas de retinóides seletivos
BR0107770A (pt) Derivados de 3-fenóxi-1-fenil acetileno e seu uso como herbicidas
BR9801150A (pt) Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
BR112015003892A2 (pt) materiais impregnados com bioflavonoides
BRPI0417948A (pt) derivados de quinuclidina substituìda por bicicloheterociclo fundido
BRPI0409831A (pt) composição de condicionamento de tecidos, e, uso de um material não iÈnico
BR0309972A (pt) Derivados de piridina carboxamida e seu uso como pesticidas
BRPI0408744A (pt) 4-feniltetrahidroisoquinolinas substituìdas, processos para preparação das mesmas, seu uso como medicamento, bem como medicamento que contém as mesmas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.